V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007746 | 280005027 | 1.68 | 82.8 | Curative (C) | 2014-05-26 | 2014-05-29 | Carboplatin AUC 6 - 10 | N | null | 280025427 | CARBOPLATIN |
| 280007747 | 280005031 | 1.86 | 65 | Neo-adjuvant (N) | 2015-05-12 | 2015-06-14 | Docetaxel+Gemcitabine (no prior RT) | 02 | Y | 280025433 | DOCETAXEL + GEMCITABINE |
| 280007748 | 280005031 | null | 18.2 | Curative (C) | 2015-08-23 | 2015-08-26 | Carboplatin AUC 6 - 10 | N | null | 280025433 | CARBOPLATIN |
| 280007749 | 280005032 | null | null | null | 2014-10-23 | 2014-10-23 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 280025444 | NOT MATCHED |
| 280007750 | 280008662 | 1.84 | 89.3 | Palliative (P) | 2016-07-05 | 2017-10-21 | Docetaxel + Gemcitabine (prior RT) | N | null | 280025446 | DOCETAXEL + GEMCITABINE |
| 280007751 | 280008663 | 1.81 | 91.5 | Palliative (P) | 2017-05-29 | 2017-06-05 | CETUXIMAB | null | null | 280025447 | CETUXIMAB |
| 280007752 | 280008663 | 1.79 | null | Curative (C) | 2015-07-31 | 2015-08-03 | Carboplatin AUC 6 - 10 | 2 | N | 280025447 | CARBOPLATIN |
| 280007753 | 280008663 | null | null | 3 | 2014-06-01 | 2014-06-04 | Carboplatin AUC 2 - 5 | 2 | Y | 280025447 | CARBOPLATIN |
| 280007754 | 280005036 | 1.69 | 70.2 | Curative (C) | 2015-04-23 | 2016-01-01 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | Y | 280025450 | NOT MATCHED |
| 280007755 | 280005037 | 1.74 | null | Palliative (P) | 2017-11-17 | 2017-12-01 | Cetuximab 7 day (>Cycle 2) | N | null | 280025454 | CETUXIMAB |
| 280007756 | 280005037 | 1.6 | 63.4 | Palliative (P) | 2016-08-23 | 2016-08-27 | Cetuximab 7 day (>Cycle 2) | N | null | 280025454 | CETUXIMAB |
| 280007757 | 280005038 | null | 71 | Not known (9) | 2013-04-25 | 2013-06-12 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280025455 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007758 | 280005041 | 1.65 | null | Curative (C) | 2013-08-08 | 2013-08-15 | CETUXIMAB | N | null | 280025457 | CETUXIMAB |
| 280007759 | 280008667 | 1.76 | 112 | Palliative (P) | 2016-12-09 | 2017-05-23 | Cetuximab 7 day (>Cycle 2) | N | N | 280025459 | CETUXIMAB |
| 280007760 | 280005044 | null | 67.7 | Neo-adjuvant (N) | 2014-03-06 | 2014-04-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 280025465 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007761 | 280010398 | 1.72 | null | Curative (C) | null | 2015-04-12 | Carboplatin AUC 2 - 5 | N | N | 280025465 | CARBOPLATIN |
| 280007762 | 280010398 | null | 55.3 | Palliative (P) | 2015-07-07 | 2015-08-07 | Carboplatin AUC 2 - 5 | Y | N | 280025465 | CARBOPLATIN |
| 280007763 | 280010398 | 1.76 | 62.75 | Not known (9) | 2018-08-30 | 2018-09-26 | Carboplatin AUC 2 - 5 | 01 | N | 280025465 | CARBOPLATIN |
| 280007764 | 280005045 | null | 76.4 | Curative (C) | null | 2018-01-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025471 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007765 | 280008669 | 1.58 | 54.7 | Curative (C) | 2016-05-15 | 2016-06-05 | Cetuximab 7 day (>Cycle 2) | Y | Y | 280025471 | CETUXIMAB |
| 280007766 | 280008670 | 1.78 | 66.2 | Curative (C) | 2013-05-17 | 2013-08-08 | Cetuximab 14 day | N | N | 280025479 | CETUXIMAB |
| 280007767 | 280008670 | 1.48 | 86.5 | Curative (C) | 2015-07-26 | 2015-07-28 | Carboplatin AUC 6 - 10 | 02 | N | 280025479 | CARBOPLATIN |
| 280007768 | 280005047 | 1.66 | 9.8 | Curative (C) | 2018-09-22 | 2018-11-01 | Carboplatin AUC 6 - 10 | N | N | 280025486 | CARBOPLATIN |
| 280007769 | 280005048 | 1.76 | 51.3 | Palliative (P) | 2018-03-25 | 2018-03-27 | Docetaxel+Gemcitabine (no prior RT) | 2 | Y | 280025489 | DOCETAXEL + GEMCITABINE |
| 280007770 | 280010401 | 0 | 71.8 | Curative (C) | 2017-03-07 | 2018-04-16 | STS Rhabdomyosarco RMS 2005 IVADoVV | null | Y | 280025489 | NOT MATCHED |
| 280007771 | 280011681 | 0 | null | Neo-adjuvant (N) | 2017-10-23 | 2017-10-23 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280025491 | NOT MATCHED |
| 280007772 | 280005049 | 1.66 | null | Adjuvant (A) | 2017-03-25 | 2017-04-07 | CETUXIMAB | N | null | 280025498 | CETUXIMAB |
| 280007773 | 280005049 | 1.65 | null | Palliative (P) | 2015-05-05 | 2015-05-19 | CETUXIMAB | 02 | null | 280025498 | CETUXIMAB |
| 280007774 | 280005050 | 1.78 | null | Curative (C) | 2015-04-15 | 2015-04-20 | CETUXIMAB | 2 | N | 280025499 | CETUXIMAB |
| 280007775 | 280005050 | 1.6 | 77 | Neo-adjuvant (N) | null | 2016-08-25 | Docetaxel+Gemcitabine (no prior RT) | 01 | N | 280025499 | DOCETAXEL + GEMCITABINE |
| 280007776 | 280008674 | 1.64 | 93.6 | Curative (C) | 2014-06-13 | 2015-04-21 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | 280025505 | NOT MATCHED |
| 280007777 | 280005053 | 1.7 | null | Curative (C) | 2015-05-21 | 2015-05-21 | Carboplatin AUC 6 - 10 | N | Y | 280025507 | CARBOPLATIN |
| 280007778 | 280005054 | 1.65 | 19.2 | Not known (9) | null | 2014-09-29 | Carboplatin AUC 6 - 10 | Y | N | 280025508 | CARBOPLATIN |
| 280007779 | 280005055 | 1.63 | 6.6 | Curative (C) | 2016-05-03 | 2016-05-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007780 | 280008675 | 1.76 | null | Curative (C) | 2016-07-16 | 2016-08-20 | Carboplatin AUC 6 - 10 | 2 | N | 280025510 | CARBOPLATIN |
| 280007781 | 280005057 | 1.71 | 69.7 | Palliative (P) | 2016-12-01 | 2016-12-01 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025512 | DOCETAXEL + GEMCITABINE |
| 280007782 | 280005057 | 0 | null | Palliative (P) | 2015-02-22 | 2015-07-04 | Carboplatin AUC 2 - 5 | N | N | 280025512 | CARBOPLATIN |
| 280007783 | 280005057 | 1.73 | 21.8 | Adjuvant (A) | 2016-10-25 | 2016-10-31 | CARBOPLATIN | N | null | 280025512 | CARBOPLATIN |
| 280007784 | 280005057 | 1.88 | 73.9 | Palliative (P) | 2016-10-01 | 2016-10-01 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | null | 280025512 | NOT MATCHED |
| 280007785 | 280005059 | null | 102.8 | Palliative (P) | 2016-02-16 | 2017-03-05 | NB HRNBL-1 COJEC Ind COURSE C | null | Y | 280025519 | NOT MATCHED |
| 280007786 | 280008679 | 0 | 90 | Curative (C) | 2017-05-07 | 2017-06-05 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 280025521 | NOT MATCHED |
| 280007787 | 280005062 | null | 58.9 | Palliative (P) | 2016-01-29 | 2016-02-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025522 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007788 | 280005064 | null | 70.2 | Palliative (P) | 2015-01-26 | 2015-02-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025524 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007789 | 280005065 | null | null | null | 2014-01-09 | 2014-01-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025524 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007790 | 280005066 | 1.7 | 90.2 | Neo-adjuvant (N) | 2018-08-17 | 2018-08-17 | DOCETAXEL + GEMCITABINE | 2 | N | 280025525 | DOCETAXEL + GEMCITABINE |
| 280007791 | 280005066 | 1.78 | 105 | Palliative (P) | 2016-04-30 | 2016-06-08 | Cetuximab 7 day (>Cycle 2) | Y | null | 280025525 | CETUXIMAB |
| 280007792 | 280005067 | 1.73 | 73.9 | Palliative (P) | 2015-12-05 | 2016-01-01 | Cetuximab 7 day (>Cycle 2) | 02 | N | 280025530 | CETUXIMAB |
| 280007793 | 280005068 | null | 71.7 | null | 2015-07-13 | 2015-08-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007794 | 280005070 | 1.8 | null | Palliative (P) | 2018-06-01 | 2018-06-03 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280025533 | NOT MATCHED |
| 280007795 | 280008685 | 1.64 | 49.8 | Palliative (P) | null | 2017-06-20 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025533 | DOCETAXEL + GEMCITABINE |